6.56 USD
↘ 0.03 (0.46%)AT CLOSE (11:59 AM EDT)
Prelude Therapeutics Incorporated
PRLDNASDAQ • USD
6.63
↗ 0.07 (1.05%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
6.63
↗ 0.07 (1.05%)
Market: CLOSED
Prelude Therapeutics Incorporated (PRLD) trades at $6.55 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, PRLD is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 26, 2026.
Open?$6.61
High?$6.71
Low?$6.37
Prev. Close?$6.59
Volume?466.3K
Avg. Volume?469.6K
VWAP?$6.55
Rel. Volume?0.99x
Bid / Ask
Bid?$6.21 × 500
Ask?$6.95 × 1.0K
Spread?$0.74
Midpoint?$6.58
Valuation & Ratios
Market Cap?523.5M
Shares Out?79.8M
Float?17.1M
Float %?39.0%
P/E Ratio?N/A
P/B Ratio?3.91
EPS?-$0.76
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
Themes
Employees
79
Market Cap
525.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-09-25
Address
175 INNOVATION BOULEVARD
WILMINGTON, DE 19805
Phone: (302) 467-1280
WILMINGTON, DE 19805
Phone: (302) 467-1280
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?3
Momentum?77
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?0.13Distress
Confidence?50%Low
Short InterestSqueeze Risk
Short % of Float?22.38%Squeeze Risk
Short Interest?3.8M
Days to Cover?9.8
Free Float17.1M
Avg Daily Volume391.4K
Settlement Date2026-08-14
Financial Health
Current Ratio?4.07Strong
Quick Ratio?4.07Strong
Cash Ratio?0.69Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.91FAIR▾
Peers100
S&P45
P/S?23.35HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-7.6CHEAP▾
S&P97
EV/Sales?22.17HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-45.2%WEAK▾
S&P3
ROA?-31.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-33255000
Enterprise Value?$497.2M
Fundamentals ratios updated end of day